Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 24 studies | 37% ± 16% | |
astrocyte | 19 studies | 39% ± 18% | |
oligodendrocyte | 16 studies | 49% ± 17% | |
oligodendrocyte precursor cell | 15 studies | 42% ± 19% | |
glutamatergic neuron | 13 studies | 52% ± 24% | |
microglial cell | 13 studies | 43% ± 13% | |
fibroblast | 13 studies | 40% ± 16% | |
GABAergic neuron | 11 studies | 49% ± 24% | |
macrophage | 11 studies | 39% ± 16% | |
pericyte | 10 studies | 38% ± 15% | |
smooth muscle cell | 10 studies | 34% ± 11% | |
adipocyte | 9 studies | 49% ± 15% | |
epithelial cell | 8 studies | 35% ± 21% | |
mast cell | 8 studies | 25% ± 10% | |
natural killer cell | 7 studies | 23% ± 8% | |
interneuron | 7 studies | 58% ± 23% | |
B cell | 7 studies | 28% ± 12% | |
myeloid cell | 7 studies | 27% ± 9% | |
dendritic cell | 7 studies | 30% ± 11% | |
T cell | 7 studies | 26% ± 8% | |
CD16-positive, CD56-dim natural killer cell, human | 6 studies | 19% ± 5% | |
neuron | 6 studies | 44% ± 18% | |
endothelial cell of lymphatic vessel | 6 studies | 40% ± 15% | |
basal cell | 6 studies | 36% ± 23% | |
plasma cell | 5 studies | 39% ± 16% | |
CD16-negative, CD56-bright natural killer cell, human | 5 studies | 22% ± 4% | |
cardiac muscle cell | 5 studies | 32% ± 9% | |
ciliated cell | 5 studies | 28% ± 9% | |
monocyte | 5 studies | 37% ± 9% | |
type I pneumocyte | 5 studies | 33% ± 8% | |
type II pneumocyte | 5 studies | 35% ± 9% | |
classical monocyte | 4 studies | 18% ± 2% | |
granule cell | 4 studies | 45% ± 7% | |
CD4-positive, alpha-beta T cell | 4 studies | 23% ± 5% | |
CD8-positive, alpha-beta T cell | 4 studies | 22% ± 4% | |
mesothelial cell | 4 studies | 40% ± 12% | |
lymphocyte | 4 studies | 33% ± 17% | |
Mueller cell | 4 studies | 35% ± 15% | |
amacrine cell | 4 studies | 40% ± 14% | |
retina horizontal cell | 4 studies | 33% ± 13% | |
retinal cone cell | 4 studies | 35% ± 13% | |
retinal rod cell | 4 studies | 41% ± 9% | |
club cell | 4 studies | 37% ± 12% | |
plasmacytoid dendritic cell | 4 studies | 20% ± 2% | |
regulatory T cell | 4 studies | 20% ± 3% | |
plasmablast | 3 studies | 26% ± 10% | |
GABAergic interneuron | 3 studies | 47% ± 1% | |
glial cell | 3 studies | 33% ± 4% | |
progenitor cell | 3 studies | 33% ± 3% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 23% ± 5% | |
non-classical monocyte | 3 studies | 21% ± 3% | |
vein endothelial cell | 3 studies | 38% ± 22% | |
GABAergic amacrine cell | 3 studies | 40% ± 15% | |
glycinergic amacrine cell | 3 studies | 37% ± 9% | |
retinal ganglion cell | 3 studies | 38% ± 16% | |
rod bipolar cell | 3 studies | 41% ± 22% | |
endothelial cell of vascular tree | 3 studies | 40% ± 21% | |
hepatocyte | 3 studies | 67% ± 16% | |
mature NK T cell | 3 studies | 23% ± 9% | |
retinal pigment epithelial cell | 3 studies | 38% ± 27% | |
neural progenitor cell | 3 studies | 43% ± 12% | |
connective tissue cell | 3 studies | 27% ± 6% | |
ependymal cell | 3 studies | 39% ± 14% | |
alveolar macrophage | 3 studies | 42% ± 11% | |
capillary endothelial cell | 3 studies | 26% ± 6% | |
myofibroblast cell | 3 studies | 34% ± 15% | |
respiratory goblet cell | 3 studies | 41% ± 15% | |
muscle cell | 3 studies | 39% ± 29% | |
goblet cell | 3 studies | 49% ± 34% | |
transit amplifying cell | 3 studies | 40% ± 34% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 20% ± 0% | |
mural cell | 3 studies | 41% ± 11% | |
mucus secreting cell | 3 studies | 39% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4118.26 | 1445 / 1445 | 100% | 13.24 | 183 / 183 |
lung | 100% | 4406.64 | 578 / 578 | 100% | 10.01 | 1154 / 1155 |
breast | 100% | 5097.79 | 459 / 459 | 100% | 14.00 | 1116 / 1118 |
prostate | 100% | 4882.84 | 245 / 245 | 100% | 12.22 | 501 / 502 |
uterus | 100% | 5484.63 | 170 / 170 | 100% | 8.86 | 457 / 459 |
brain | 100% | 3542.65 | 2630 / 2642 | 100% | 12.06 | 705 / 705 |
thymus | 100% | 5542.32 | 653 / 653 | 99% | 11.20 | 600 / 605 |
adrenal gland | 100% | 3823.68 | 258 / 258 | 99% | 11.32 | 228 / 230 |
pancreas | 100% | 3978.78 | 328 / 328 | 99% | 9.21 | 176 / 178 |
kidney | 100% | 2985.91 | 89 / 89 | 98% | 10.74 | 887 / 901 |
bladder | 100% | 4312.71 | 21 / 21 | 98% | 7.64 | 494 / 504 |
ovary | 100% | 5673.87 | 180 / 180 | 98% | 6.08 | 420 / 430 |
stomach | 100% | 3832.52 | 359 / 359 | 98% | 8.39 | 279 / 286 |
intestine | 100% | 4408.05 | 966 / 966 | 96% | 7.01 | 508 / 527 |
skin | 100% | 5325.59 | 1809 / 1809 | 96% | 9.48 | 452 / 472 |
liver | 100% | 3341.10 | 226 / 226 | 93% | 5.81 | 377 / 406 |
adipose | 100% | 4807.17 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5385.80 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 5163.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 9.37 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.36 | 1 / 1 |
muscle | 99% | 1824.36 | 791 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 2315.49 | 847 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 6.12 | 25 / 29 |
peripheral blood | 73% | 1820.17 | 681 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 70% | 4.39 | 56 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015031 | Biological process | protein transport |
GO_0006895 | Biological process | Golgi to endosome transport |
GO_0031901 | Cellular component | early endosome membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005515 | Molecular function | protein binding |
Gene name | MON2 |
Protein name | MON2 homolog, regulator of endosome-to-Golgi trafficking ATP synthase protein 8 (A6L) (F-ATPase subunit 8) Protein MON2 homolog Protein MON2 homolog (Protein SF21) |
Synonyms | KIAA1040 SF21 |
Description | FUNCTION: Plays a role in regulating membrane trafficking of cargo proteins. Together with ATP9A and DOP1B, regulates SNX3 retromer-mediated endosomal sorting of WLS away from lysosomal degradation. . |
Accessions | ENST00000641654.1 A0A286YFF8 ENST00000393629.6 [Q7Z3U7-5] Q6P148 Q7Z3U7 F8VQS2 F8VZV6 ENST00000547095.5 ENST00000546600.5 [Q7Z3U7-2] ENST00000393630.8 [Q7Z3U7-1] B7ZM73 F8VZV1 ENST00000549286.1 ENST00000552738.5 [Q7Z3U7-6] ENST00000552115.5 |